3 US lawmakers question FDA's foreign drug inspection program discrepancies in India and China.
Three top US lawmakers, including Cathy McMorris Rodgers, Brett Guthrie, and Morgan Griffith, have raised concerns over the US Food and Drug Administration's (FDA) foreign drug inspection program in India and China, questioning the significant discrepancies in inspection outcomes and institutional weaknesses within the program. They analyzed FDA inspections from January 2014 to April 2024, revealing large variations in inspection outcomes, and called for more information regarding the agency's foreign drug inspection program.
June 25, 2024
7 Articles